Published: Thursday, December 11, 2025 OKLAHOMA CITY The success of GLP-1 medications for treating Type 2 diabetes and obesity naturally leads to a related question: Do GLP-1 drugs affect cancer risk, which is often associated with obesity and Type 2 diabetes
That dose is for tolerability, not weight loss
Adjustment to the Amount in Controversy Threshold Amounts for Calendar Year 2026." Federal Register, December 4, 2025
Heart disease Diabetes Heart attack Fatty liver disease Cancer Less stress on your joints & organs Easier breathing Better sleep More energy Manage Your Weight If your BMI is 30 or higher, losing just 3% to 5% of your total weight is enough to start to see positive health changes
Piatti PM, Monti LD, Valsecchi G, Magni F, Setola E, Marchesi F, Galli-Kienle M, Pozza G, Alberti KG
In the brain, GHK-Cu has shown promise in animal models: protecting memory under sleep deprivation, producing rapid anti-anxiety effects, and reducing stress-induced damage